ethoglucid has been researched along with Invasiveness, Neoplasm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, PH | 1 |
| Ay, R; de Pauw, M; Debruyne, F; Kurth, K; Pavone-Macaluso, M; Schröder, FH; Sylvester, R; ten Kate, F; Tunn, U | 1 |
| Chisholm, GD; Elton, RA; Hargreave, TB; Newsam, JE; Smith, G | 1 |
1 review(s) available for ethoglucid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Chemotherapy of bladder cancer: a review.
Topics: Administration, Topical; Antineoplastic Agents; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Ethoglucid; Europe; Humans; Neoplasm Invasiveness; Prognosis; Random Allocation; Thiotepa; Urinary Bladder Neoplasms | 1981 |
2 trial(s) available for ethoglucid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Chemotherapy of bladder cancer: a review.
Topics: Administration, Topical; Antineoplastic Agents; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Ethoglucid; Europe; Humans; Neoplasm Invasiveness; Prognosis; Random Allocation; Thiotepa; Urinary Bladder Neoplasms | 1981 |
Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Disease Progression; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Time Factors; Urinary Bladder Neoplasms | 1997 |
1 other study(ies) available for ethoglucid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases.
Topics: Administration, Intravesical; Carcinoma, Transitional Cell; Ethoglucid; Humans; Methotrexate; Mitomycin; Mitomycins; Neoplasm Invasiveness; Neoplasm Metastasis; Prognosis; Urinary Bladder Neoplasms | 1986 |